Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimuscarinics vs α-blockers for Men With LUTS and IPSS-V/S ≤1
NCT01661621Phase 4Completed
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Aug 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tolterodine in lower urinary tract symptoms (LUTS) and bladder outlet obstruction (BOO) (2 arms), sponsored by Buddhist Tzu Chi General Hospital. Primary endpoint: Global Response Assessment at 1 month. Started Aug 2012; status: completed.
02
Drugs
tolterodine
03
Conditions
lower urinary tract symptoms (LUTS)bladder outlet obstruction (BOO)
Beyond the preview
Go deeper on NCT01661621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01661621.